Interestingly, we observed that Hakin-1 treatment reduced tumour growth in Hakai-MDCK tumour xenografts, on which E-cadherin was not expressed, and this effect was accompanied by a reduced expression of N-cadherin mesenchymal marker and reduced formation of lung micrometastases. Here, CDH2 is linked to neoplasm.